+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Secnidazole"

Bacterial Vaginosis Drug Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Dosage Form, Distribution Channel, and Geography - Product Thumbnail Image

Bacterial Vaginosis Drug Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Dosage Form, Distribution Channel, and Geography

  • Report
  • February 2025
  • 184 Pages
  • Global
From
Bacterial Vaginosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Bacterial Vaginosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Secnidazole (CAS 3366-95-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Secnidazole (CAS 3366-95-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • May 2025
  • 50 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Secnidazole is an antibiotic used to treat a variety of infectious diseases. It is a nitroimidazole drug, which works by inhibiting the growth of bacteria and protozoa. It is used to treat bacterial infections such as urinary tract infections, skin infections, and sexually transmitted diseases. It is also used to treat protozoal infections such as giardiasis and trichomoniasis. Secnidazole is available in tablet, capsule, and suspension forms. Secnidazole is a widely used drug in the treatment of infectious diseases. It is effective against a wide range of bacteria and protozoa, and is well tolerated by patients. It is also cost-effective, making it an attractive option for many healthcare providers. Some companies that produce secnidazole include Sanofi, Merck, Pfizer, and GlaxoSmithKline. Show Less Read more